Regulus Therapeutics (RGLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,121 | 13,935 | 13,519 | 14,941 | 17,216 |
| Marketable Securities | N/A | N/A | 46,555 | 61,170 | 98,103 |
| Receivables | 1,141 | 26 | 373 | 1,657 | 10,021 |
| TOTAL | $40,407 | $19,295 | $66,736 | $87,474 | $134,258 |
| Non-Current Assets | |||||
| PPE Net | 921 | 7,806 | 9,708 | 11,830 | 5,400 |
| Intangibles | 266 | 500 | 775 | 1,015 | 1,081 |
| Other Non-Current Assets | 487 | 326 | 590 | 342 | 344 |
| TOTAL | $1,674 | $8,632 | $11,073 | $13,187 | $6,825 |
| Total Assets | $42,081 | $27,927 | $77,809 | $100,661 | $141,083 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 14,631 | 16,575 | 19,859 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,321 | 1,714 | 5,743 | 5,840 | 2,717 |
| Accrued Expenses | 2,593 | 3,226 | 6,926 | 7,895 | 8,721 |
| Other current liabilities | 3,053 | 5,131 | 72 | N/A | N/A |
| TOTAL | $21,598 | $26,646 | $32,600 | $13,807 | $12,632 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 19,802 | N/A |
| Deferred Revenues | N/A | N/A | N/A | 72 | 1,194 |
| Other Non-Current Liabilities | 468 | 315 | 1,921 | 144 | 0 |
| TOTAL | $468 | $7,135 | $9,993 | $30,779 | $4,373 |
| Total Liabilities | $22,066 | $33,781 | $42,593 | $44,586 | $17,005 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,104 | 1,074 | 866 | 441 | 439 |
| Common Shares | 21 | 9 | 9 | 53 | 53 |
| Retained earnings | -411,315 | -392,723 | -345,858 | -273,351 | -191,515 |
| Other shareholders' equity | 4 | 0 | -134 | -123 | -133 |
| TOTAL | $20,015 | $-5,854 | $35,216 | $56,075 | $124,078 |
| Total Liabilities And Equity | $42,081 | $27,927 | $77,809 | $100,661 | $141,083 |